Indivior logo

INDV - Indivior News Story

134p 0.8  0.6%

Last Trade - 16/04/21

Mid Cap
Market Cap £984.4m
Enterprise Value £570.1m
Revenue £467.8m
Position in Universe 438th / 1819

Indivior PLC - Claim filed by Reckitt Benckiser Group plc

Fri 27th November, 2020 10:44am
RNS Number : 7714G
Indivior PLC
27 November 2020




Claim filed by Reckitt Benckiser Group plc

Indivior PLC (the 'Company') has been made aware that a claim was submitted to the Commercial Court in London by Reckitt Benckiser Group plc ('RB') against the Company on November 13, 2020 pursuant to an indemnity contained in the Demerger Agreement entered into between RB and the Company on November 17, 2014.  The amount claimed under the submission is £1,073,622.580.51.

The claim has not been served on the Company and the Company does not have any further details at this time.  The Company will assess with its advisors the background and merits to the case and will provide an update in due course.




For Further Information

Investor Enquiries


Jason Thompson

VP, Investor Relations Indivior PLC

+1 804 402 7123

Media Enquiries

Jonathan Sibun

Tulchan Communications

US Media Inquiries


+44 207 353 4200

+1 804 594 0836




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.